GT Biopharma reports Q1 results
Source: SeekingAlpha
2026-05-15 08:38:39 ET
More on GT Biopharma
- GT Biopharma reports FY results
- Seeking Alpha’s Quant Rating on GT Biopharma
- Historical earnings data for GT Biopharma
- Financial information for GT Biopharma
Read the full article on Seeking Alpha
For further details see:
GT Biopharma reports Q1 results
GT Biopharma Inc.
NASDAQ: GTBP
GTBP Trading
-6.07% G/L:
$0.4133 Last:
2,036,695 Volume:
$0.4508 Open:
GTBP Latest News
May 14, 2026 12:45:00 pm
First Patient Dosed in Phase 1 Trial Marks Expansion of NK Cell Engager Platform Into Solid TumorsMay 14, 2026 10:55:00 am
"Cold" Solid Tumors Become the Proving Ground for a New Generation of Engager and Immune-Priming TherapiesMay 14, 2026 09:15:00 am
A Cancer Antigen Long Thought Untouchable Is Suddenly the Hottest Target in OncologyGTBP Stock Data
$13,901,784
16,849,517
7.73%
17
N/A
Biotechnology & Life Sciences
Healthcare
US
San Francisco
